|
Exploring Novel Treatments for Rett Syndrome
STATEMENT OF NEED
Rett syndrome is a rare, debilitating neurodevelopmental disorder almost always associated with a spontaneous mutation in the methyl-CpG-binding protein 2 (MECP2) gene on the X-chromosome. Affected individuals experience loss of purposeful hand skills, abnormalities in gait, loss of spoken language, and stereotypic hand movements, with more severe manifestations including seizures, autistic features, autonomic nervous system dysfunction, breathing abnormalities, sleep dist... |
|
|
The IMPACT Initiative Learning Center: Ultrasound Basics
Target Audience
This activity is intended for neurologists, physiatrists, orthopedic surgeons, residents, fellows, nurse practitioners, physician assistants, physical therapists, and occupational therapists who manage patients with spasticity and movement disorders.
Program Overview
This activity provides an overview of how to identify muscles/other structures with ultrasound and procedural guidance for botulinum neurotoxin injections, including scanning tips and guidance techniques f... |
|
|
The IMPACT Initiative Learning Center: Head and Neck Including the Salivary Gland
Target Audience
This activity is intended for neurologists, physiatrists, orthopedic surgeons, residents, fellows, nurse practitioners, physician assistants, physical therapists, and occupational therapists who manage patients with spasticity and movement disorders.
Program Overview
This activity provides an update on using ultrasound guidance to optimize procedural guidance for head and neck botulinum neurotoxin (BoNT) injection including ultrasound pattern recognition, scanning tips... |
|
|
The IMPACT Initiative Learning Center: Shoulder and Arm
Target Audience
This activity is intended for neurologists, physiatrists, orthopedic surgeons, residents, fellows, nurse practitioners, physician assistants, physical therapists, and occupational therapists who manage patients with spasticity and movement disorders.
Program Overview
This activity reviews utilization of ultrasound guidance for optimizing botulinum neurotoxin (BoNT) injections in the shoulder girdle region including pattern recognition, scanning tips, and needle guidanc... |
|
|
The IMPACT Initiative Learning Center: Hip Girdle and Thigh
Target Audience
This activity is intended for neurologists, physiatrists, orthopedic surgeons, residents, fellows, nurse practitioners, physician assistants, physical therapists, and occupational therapists who manage patients with spasticity and movement disorders.
Program Overview
This activity reviews use of ultrasound guidance for optimizing botulinum neurotoxin injections in the hip girdle region including pattern recognition, scanning tips, and needle guidance technique.
Lear... |
|
|
The IMPACT Initiative Learning Center: Lower Limb/leg and Calf Region
Target Audience
This activity is intended for neurologists, physiatrists, orthopedic surgeons, residents, fellows, nurse practitioners, physician assistants, physical therapists, and occupational therapists who manage patients with spasticity and movement disorders.
Program Overview
This activity reviews use of ultrasound guidance for optimizing botulinum neurotoxin injections in the leg and calf region including pattern recognition, scanning tips, and needle guidance techniques
Le... |
|
|
The IMPACT Initiative Learning Center: Forearm and Hand
Target Audience
This activity is intended for neurologists, physiatrists, orthopedic surgeons, residents, fellows, nurse practitioners, physician assistants, physical therapists, and occupational therapists who manage patients with spasticity and movement disorders.
Program Overview
This activity reviews use of ultrasound guidance for optimizing botulinum neurotoxin injections in the forearm and hand including pattern recognition, scanning tips, and needle guidance techniques.
Lear... |
|
|
Exploring Advances in the Early Diagnosis and Treatment of Alzheimer Disease
STATEMENT OF NEED
Alzheimer disease, the most common form of dementia among older adults, is a slowly progressive neurogenerative disease that affects approximately 6 million Americans aged 65 and older (Rajan et al, 2021). Symptoms of Alzheimer disease include memory loss, confusion, impulsive behavior, difficulty with language, mood and personality changes, hallucinations, and increased anxiety or aggression, with severe symptoms such as physical decline, difficulty swallowing, and inabil... |
|
|
Allies in the Race Against Time: Navigating Alzheimer's Disease with Early Detection, Therapeutic Innovations, and Patient-Centric Care " Module Three
Target Audience
This activity is designed to meet the educational needs of healthcare professionals who provide care for patients primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants
Program Overview
Alzheimer's disease (AD) is a progressive and devastating neurodegenerative disorder that affects a significant portion of the elderly population and is increasing globally. Recent advancements in diseas... |
|
|
Allies in the Race Against Time: Navigating Alzheimer's Disease with Early Detection, Therapeutic Innovations, and Patient-Centric Care " Module Four
Target Audience
This activity is designed to meet the educational needs of healthcare professionals who provide care for patients primary care clinicians including internists, family physicians, radiologists, neurologists, nurse practitioners and physician assistants.
Program Overview
Alzheimer's disease (AD) is a progressive and devastating neurodegenerative disorder that affects a significant portion of the elderly population and is increasing globally. Recent advancements in disea... |
|
|
Improving Alzheimer’s Disease Management: Updates on Patient Diagnosis and Treatment
The face of mild cognitive impairment (MCI) and Alzheimer’s disease (AD) diagnosis and management is rapidly changing. A growing understanding of AD pathophysiology has shaped research of targeted therapies and helped clinicians better understand the causes of the disease and the utility of biomarkers. Though cognitive testing is still a critical component of diagnosis, it no longer stands alone. Biomarkers are increasingly incorporated into practice to aid in diagnosis of MCI and AD and to ... |
|
|
New Vistas in Prostate Cancer Imaging (Streaming Online & USB Drive)
As the need to identify and treat prostate cancer increases, imaging is a critical tool in its diagnosis, staging and surveillance. New Vistas in Prostate Cancer Imaging is designed to help radiologists, oncologists, radiation oncologists and urologists master this continually evolving technology. This activity analyzes the two most promising imaging modalities for prostate cancer: multiparametric MRI and PSMA PET/CT. Essential concepts and multiple cases in both modalities are reviewed throug... |
|
|
Updates on the Evolving Role of Multidisciplinary Care Teams for the Management of Patients with Duchenne Muscular Dystrophy
Target Audience
These educational activities are designed for neurologists, pediatric neurologists, global pharmacists, specialty nurses, genetic counselors, medical geneticists, and other physicians involved in multidisciplinary care teams for DMD management.
Program Overview
This enduring activity focuses on improving the care of patients with Duchenne muscular dystrophy (DMD) with regard to effective diagnosis, referral, and treatment. Additionally, the faculty will aim to present stan... |
|
|
Exploring New Treatment Advances for Acid Sphingomyelinase Deficiency in Adults
STATEMENT OF NEED
Acid sphingomyelinase deficiency (ASMD) is a rare, hereditary lysosomal storage disease with multisystemic manifestations, including splenomegaly, hepatomegaly, interstitial lung disease, dyslipidemia, bone marrow and lymph node involvement, and sometimes neurological and peripheral nerve involvement. While the most severe form of ASMD, infantile neurovisceral ASMD, results in death in early childhood, chronic forms of ASMD have more prolonged survival but are associated w... |
|
|
Case Studies in Multiple Sclerosis and Aging
• Identify the clinical difference between age-related/neurodegenerative cognitive decline and MS-related cognitive impairment.
• Discuss the role of potential biomarkers in identifying coexisting neurodegenerative disorders.
• Explain why it is important for the care team to address comorbid vascular risk factors for cognitive decline, including lifestyle modification and healthy behaviors
https://academycme.org/pdfs/MSAging.pdf |
|
|
Penn Radiology Comprehensive Neuroradiology: Imaging Ideals (Streaming Online & USB Flash Drive)
Penn Radiology’s renowned faculty provides a thorough review of best practices in Neuroradiology. Comprehensive Neuroradiology: Imaging Ideals will benefit imagers, neurologists and neurosurgeons with an extremely detailed analysis of anatomy, techniques, modalities and procedures. Worth 23 AMA PRA Category I Credits™, applicable toward Maintenance of Certification requirements.
Topics: Neoplastic and non-neoplastic disorders of the brain, spine, head and neck, acute stroke, trauma, t... |
|